Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seguro

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 StudyLeonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
The Lancet. Rheumatology|December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective studyNadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Arquivos Brasileiros De Cardiologia|October 19, 2018
Fernando Bacal, Fabiana G Marcondes-Braga, Luis Eduardo Paim Rohde, et al.
The Lancet. Rheumatology|February 12, 2026
Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority studyNadia E Aikawa, Ana C Medeiros-Ribeiro, Sandra G Pasoto, et al.
Nature Communications|October 3, 2022
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patientsClovis A Silva, Ana C Medeiros-Ribeiro, Leonard V K Kupa, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 StudyLeonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
The Lancet. Rheumatology|December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective studyNadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Arquivos Brasileiros De Cardiologia|October 19, 2018
Fernando Bacal, Fabiana G Marcondes-Braga, Luis Eduardo Paim Rohde, et al.
The Lancet. Rheumatology|February 12, 2026
Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority studyNadia E Aikawa, Ana C Medeiros-Ribeiro, Sandra G Pasoto, et al.
Nature Communications|October 3, 2022
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patientsClovis A Silva, Ana C Medeiros-Ribeiro, Leonard V K Kupa, et al.
Pageof 15